Samueli School of Engineering

Background

Point-of-care (POC) diagnostics provide quick results for patients in remote areas with limited access to laboratory equipment. Concurrently in-vitro diagnostic device market is a valued at $24 billion dollar and its expected to be valued at over $70 billion by 2020 • These diagnostics require access to intracellular components, such as DNA, which can be accessed by bursting open the cell, a process called cell lysis. Microfluidic technology allows for an entire laboratory procedure to miniaturized onto a small, portable platform, allowing for a quicker diagnostics and results.

Andrew Chavarin, Leovi Espitia, Saffi Khan, Marisa Lopez, Frederique Norpetlian, Abdullaah Tarif

Advisor: Professor William C. Tang

Mentor: Dr. Brad Sargent, Omnica Corporation, Irvine, CA

School of Engineering

Department of: Biomedical Engineering, Chemical and Material Science & Mechanical and Aerospace Engineering,

University of California-Irvine, CA